JP2012092103A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092103A5
JP2012092103A5 JP2011237399A JP2011237399A JP2012092103A5 JP 2012092103 A5 JP2012092103 A5 JP 2012092103A5 JP 2011237399 A JP2011237399 A JP 2011237399A JP 2011237399 A JP2011237399 A JP 2011237399A JP 2012092103 A5 JP2012092103 A5 JP 2012092103A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoro
chloro
bromo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011237399A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092103A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012092103A publication Critical patent/JP2012092103A/ja
Publication of JP2012092103A5 publication Critical patent/JP2012092103A5/ja
Pending legal-status Critical Current

Links

JP2011237399A 2004-12-09 2011-10-28 エストロゲン受容体モジュレーター Pending JP2012092103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63478504P 2004-12-09 2004-12-09
US60/634,785 2004-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007545542A Division JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター

Publications (2)

Publication Number Publication Date
JP2012092103A JP2012092103A (ja) 2012-05-17
JP2012092103A5 true JP2012092103A5 (enExample) 2013-01-17

Family

ID=36578441

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007545542A Withdrawn JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター
JP2011237399A Pending JP2012092103A (ja) 2004-12-09 2011-10-28 エストロゲン受容体モジュレーター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007545542A Withdrawn JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター

Country Status (15)

Country Link
US (1) US7511152B2 (enExample)
EP (1) EP1827421B1 (enExample)
JP (2) JP2008523065A (enExample)
KR (1) KR20070085874A (enExample)
CN (1) CN101087606B (enExample)
AU (1) AU2005314230B2 (enExample)
BR (1) BRPI0518874A2 (enExample)
CA (1) CA2590860C (enExample)
IL (1) IL183543A (enExample)
MX (1) MX2007006878A (enExample)
NO (1) NO20073511L (enExample)
NZ (1) NZ555316A (enExample)
RU (1) RU2394820C2 (enExample)
WO (1) WO2006062876A2 (enExample)
ZA (1) ZA200704223B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134243A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7923568B2 (en) 2005-10-05 2011-04-12 Merck Sharp & Dohme Corp. Estrogen receptor modulators
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
WO2008091555A2 (en) 2007-01-22 2008-07-31 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
EP2182965A4 (en) * 2007-08-08 2010-09-29 Bionovo Inc LIGUSTRUM LUCIDUM EXTRACTS AND USES THEREOF
US9339523B2 (en) * 2007-09-07 2016-05-17 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae family and uses thereof
WO2009033075A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
CA2706315A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
EP2222322A4 (en) * 2007-11-19 2012-07-25 Bionovo Inc EXTRACT OF SCUTELLARIA BARBATA AND COMBINATIONS CONTAINING IT FOR THE TREATMENT OF CANCER
EP2219659A4 (en) 2007-11-19 2010-11-17 Bionovo Inc METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
EP2276480A4 (en) * 2008-04-14 2011-08-10 Bionovo Inc CALYCOSINE AND ITS ANALOGUE FOR THE TREATMENT OF ESTROGEN RECEPTOR-BETA-MEDIATED ILLNESSES
WO2009137534A2 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
EP2303249A4 (en) * 2008-06-06 2012-05-30 Bionovo Inc ANTHRAQUINONES AND ANALOGS FROM RHEUM PALMATUM FOR THE TREATMENT OF MEDIA CONDITIONS BY THE STROGEN BETA RECEPTOR
AU2009289644A1 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
AU2010246233A1 (en) * 2009-04-28 2011-12-22 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
AU2014359178A1 (en) 2013-12-05 2016-07-21 Karo Pharma Ab Estrogen receptor beta agonists for use in treating mesothelioma
KR20180095564A (ko) * 2015-12-22 2018-08-27 지앙수 헨그루이 메디슨 컴퍼니 리미티드 벤조피페리딘 유도체, 이의 제조 방법 및 이의 의학적 용도

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4294926A (en) 1979-06-15 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5889191A (ja) 1981-11-20 1983-05-27 Sankyo Co Ltd 3−ヒドロキシ−ml−236b誘導体の製造法
WO1984002131A1 (fr) 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US4911165A (en) 1983-01-12 1990-03-27 Ethicon, Inc. Pliabilized polypropylene surgical filaments
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4885314A (en) 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4782084A (en) 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4820850A (en) 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5180589A (en) 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US4916239A (en) 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
US5290946A (en) 1988-10-13 1994-03-01 Sandoz Ltd. Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
US5118853A (en) 1988-10-13 1992-06-02 Sandoz Ltd. Processes for the synthesis of 3-disubstituted aminoacroleins
US4929437A (en) 1989-02-02 1990-05-29 Merck & Co., Inc. Coenzyme Q10 with HMG-CoA reductase inhibitors
US5189164A (en) 1989-05-22 1993-02-23 Sandoz Ltd. Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
US5298627A (en) 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
DE19523446A1 (de) * 1995-06-28 1997-01-02 Bayer Ag Benzotriazole
JP2002539191A (ja) 1999-03-15 2002-11-19 アクシス・ファーマシューティカルズ・インコーポレイテッド プロテアーゼ阻害剤としての新規化合物及び組成物
JP2003525874A (ja) 2000-01-06 2003-09-02 メルク フロスト カナダ アンド カンパニー プロテアーゼ阻害剤としての新規化合物および組成物
JP4331913B2 (ja) * 2000-02-14 2009-09-16 メルク エンド カムパニー インコーポレーテッド エストロゲンレセプターモデュレーター
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
DE60113537T3 (de) * 2000-06-20 2013-05-29 Novartis Ag Methode zur verabreichung von biphosphonaten
AU2002226965B2 (en) 2000-11-27 2006-05-18 Merck Sharp & Dohme Corp. Estrogen receptor modulators
EP1418900A4 (en) * 2001-08-13 2006-01-25 Merck & Co Inc SELECTIVE ESTROGEN RECEPTOR MODULATORS
CA2497934A1 (en) 2002-09-19 2004-04-01 Merck & Co., Inc. Tryptophan hydroxylase assay
AR051597A1 (es) * 2004-11-01 2007-01-24 Merck & Co Inc Moduladores de los receptores de estrogeno

Similar Documents

Publication Publication Date Title
JP2012092103A5 (enExample)
JP2016503793A5 (enExample)
JP2011105738A5 (enExample)
JP2010536766A5 (enExample)
JP2009535462A5 (enExample)
JP2010501534A5 (enExample)
JP2010504286A5 (enExample)
JP2013521295A5 (enExample)
JP2013537203A5 (enExample)
JP2016503797A5 (enExample)
JP2013532130A5 (enExample)
JP2013032389A5 (enExample)
JP2014526533A5 (enExample)
JP2014508753A5 (enExample)
JP2011518833A5 (enExample)
JP2010095546A5 (enExample)
JP2014500861A5 (enExample)
JP2016540742A5 (enExample)
JP2015512931A5 (enExample)
JP2015516427A5 (enExample)
JP2015199738A5 (enExample)
JP2013102146A5 (ja) 化合物
JP2015512883A5 (enExample)
JP2013532687A5 (enExample)
JP2011227454A5 (enExample)